PIK3CA and non-small cell lung carcinoma: Studies have found highly activated HER3 with somatic mutations of EGFR in NSCLC.53 HER3 becomes potently trans-phosphorylated and activated by binding with mutated EGFR and mediates the PI3K/AKT pathway.